Publications (original articles or review articles) published in 2024 from OUS - Department of Infectious Diseases
24 publications found
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
NPJ Vaccines, 9 (1), 185
DOI 10.1038/s41541-024-00972-3, PubMed 39384763
Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy
Front Immunol, 15, 1350593
DOI 10.3389/fimmu.2024.1350593, PubMed 38433842
A prospective, multicenter study of hepatitis B birth-dose vaccine with or without hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus in Ethiopia
Vaccine, 42 (26), 126461
DOI 10.1016/j.vaccine.2024.126461, PubMed 39426287
Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients
J Intern Med, 296 (1), 80-92
DOI 10.1111/joim.13783, PubMed 38539241
Transport of Patients With High-Consequence Infectious Diseases: Development of European Capacity in Norway
Health Secur, 22 (S1), S76-S85
DOI 10.1089/hs.2023.0153, PubMed 39137054
Prolonged hospitalization signature and early antibiotic effects on the nasopharyngeal resistome in preterm infants
Nat Commun, 15 (1), 6024
DOI 10.1038/s41467-024-50433-7, PubMed 39019886
Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages
J Infect, 88 (5), 106155
DOI 10.1016/j.jinf.2024.106155, PubMed 38574775
Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study
Acta Anaesthesiol Scand, 68 (4), 502-511
DOI 10.1111/aas.14376, PubMed 38286568
Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release
Int J Mol Sci, 25 (13)
DOI 10.3390/ijms25137141, PubMed 39000248
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
World J Hepatol, 16 (7), 995-1008
DOI 10.4254/wjh.v16.i7.995, PubMed 39086536
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
Aliment Pharmacol Ther, 60 (4), 434-445
DOI 10.1111/apt.18147, PubMed 38970293
Ex-situ liver resection for complex Echinococcus multilocularis infection: a case report
J Surg Case Rep, 2024 (6), rjae410
DOI 10.1093/jscr/rjae410, PubMed 38868544
Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region
HIV Med, 25 (6), 700-710
DOI 10.1111/hiv.13619, PubMed 38361216
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial
Viruses, 16 (6)
DOI 10.3390/v16060858, PubMed 38932151
Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study
Antimicrob Resist Infect Control, 13 (1), 140
DOI 10.1186/s13756-024-01494-2, PubMed 39580437
The WHO atlas for female-genital schistosomiasis: Co-design of a practicable diagnostic guide, digital support and training
PLOS Glob Public Health, 4 (3), e0002249
DOI 10.1371/journal.pgph.0002249, PubMed 38498490
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial
Clin Infect Dis, 78 (3), 582-590
DOI 10.1093/cid/ciad711, PubMed 37992203
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study
Front Immunol, 15, 1379570
DOI 10.3389/fimmu.2024.1379570, PubMed 38957465
Predictors for participation in mass-treatment and female genital schistosomiasis re-investigation, and the effect of praziquantel treatment in South African adolescents
PLoS Negl Trop Dis, 18 (3), e0011798
DOI 10.1371/journal.pntd.0011798, PubMed 38536861
The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth
J Infect Dis, 229 (3), 888-897
DOI 10.1093/infdis/jiad390, PubMed 37721470
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
Commun Med (Lond), 4 (1), 231
DOI 10.1038/s43856-024-00650-4, PubMed 39533001
Protein and transcriptional biomarker profiling may inform treatment strategies in lower respiratory tract infections by indicating bacterial-viral differentiation
Microbiol Spectr, 12 (10), e0283123
DOI 10.1128/spectrum.02831-23, PubMed 39269158
High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
J Intern Med, 296 (3), 249-259
DOI 10.1111/joim.13820, PubMed 39011800
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
EBioMedicine, 111, 105511
DOI 10.1016/j.ebiom.2024.105511, PubMed 39731852